Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).
- Journal:
- Journal of Clinical Oncology
- Published:
- DOI:
- 10.1200/jco-25-01546
- Affiliations:
- 13
- Authors:
- 32
| Institutions | Authors | Share |
|---|---|---|
| Tata Memorial Hospital (TMH), TMC, India | 0.47 | |
| Homi Bhabha National Institute (HBNI), India | 0.47 | |
| Gunvati Jagan Nath Kapoor Foundation, India | 0.03 | |
| SunAct, India | 0.02 | |
| P.D. Hinduja Hospital and Medical Research Center, India | 0.02 |